Saccharomyces cerevisiae, IgA

Optimal result: 0 – 20 Units

Saccharomyces cerevisiae IgA antibodies are found in about 35% of CD patients but less than 1% in UC patients.

A positive ASCA (Anti-Saccharomyces cerevisiae antibodies) result is not diagnostic of CD, UC, or of an IBD, but it does make it more likely that a person with symptoms has an IBD.

Results of ASCA testing are often interpreted in conjunction with the results of pANCA testing:

- If ASCA is positive and pANCA is negative, then it is likely that the person has Crohn disease (CD).
- If ASCA is negative and pANCA is positive, then it is likely that the person has Ulcerative colitis (UC).

Anti-Saccharomyces cerevisiae antibodies (ASCA) are immune proteins found in people with inflammatory bowel disease (IBD), which is a chronic condition characterized by swollen and damaged tissues in the intestinal tract. The ASCA test detects these antibodies in the blood. ASCA can help distinguish between Crohn disease (CD) and ulcerative colitis (UC), the two most common types of inflammatory bowel disease (IBD).

IgA and IgG antibody testing for S. cerevisiae is useful adjunct testing for differentiating Crohn's disease and ulcerative colitis. Close to 80% of Crohn's disease patients are positive for either IgA or IgG. In ulcerative colitis, less than 15% are positive for IgG and less than 2% are positive for IgA. Fewer than 5% are positive for either IgG or IgA antibody, and no healthy controls had antibody for both.

Saccharomyces cerevisiae IgA antibodies are found in about 35% of CD patients but less than 1% in UC patients. Detection of both Saccharomyces IgG and IgA antibodies in the same serum specimen is highly specific for CD.

Anti-Saccharomyces cerevisiae antibodies (ASCA) are immune proteins found in people with inflammatory bowel disease (IBD), which is a chronic condition characterized by swollen and damaged tissues in the intestinal tract. The ASCA test detects these antibodies in the blood.

Saccharomyces cerevisiae, also known as S. cerevisiae, is a common type of yeast found in various foods. The relationship between the presence of S. cerevisiae antibodies and their involvement in the development of inflammatory bowel disease is currently not understood.

IBD can vary in symptoms and severity from person to person. It often involves flare-ups followed by periods of reduced symptoms or remission. The two main types of IBD are Crohn disease (CD) and Ulcerative colitis (UC). CD can affect any part of the intestinal tract, primarily the small intestine and/or colon, while UC specifically occurs in the colon.

Diagnosing CD or UC typically involves endoscopic testing and examining biopsy samples from the intestines. Since both CD and UC can affect the colon, it can be challenging to differentiate between the two using biopsies alone. In such cases, ASCA testing may be helpful because ASCA is more frequently found in people with CD compared to those with UC.

The body produces two classes of Saccharomyces cerevisiae antibodies, ASCA IgG and ASCA IgA. The testing usually includes both classes. ASCA IgG levels can potentially indicate the severity of the disease and the need for surgery as a treatment option.

Saccharomyces cerevisiae, IgA
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Saccharomyces cerevisiae, IgA — 10,000+ markers explained
One Saccharomyces cerevisiae, IgA result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro